Skip to main content
Erschienen in: neurogenetics 4/2008

01.10.2008 | Original Article

Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease

verfasst von: Jung Mi Choi, Myoung Soo Woo, Hyeo-Il Ma, Suk Yun Kang, Young-Hee Sung, Seok Woo Yong, Sun Ju Chung, Joong-Seok Kim, Hae-won Shin, Chul Hyoung Lyoo, Phil Hyu Lee, Jong Sam Baik, Sang-Jin Kim, Mee Young Park, Young Ho Sohn, Jin-Ho Kim, Jae Woo Kim, Myung Sik Lee, Myoung Chong Lee, Dong-Hyun Kim, Yun Joong Kim

Erschienen in: Neurogenetics | Ausgabe 4/2008

Einloggen, um Zugang zu erhalten

Abstract

Mutations in five PARK genes (SNCA, PARKIN, DJ-1, PINK1, and LRRK2) are well-established genetic causes of Parkinson disease (PD). Recently, G2385R substitution in LRRK2 has been determined as a susceptibility allele in Asian PD. The objective of this study is to determine the frequency of mutations in these PARK genes in a Korean early-onset Parkinson disease (EOPD) cohort. The authors sequenced 35 exons in SNCA, PARKIN, DJ-1, PINK1, and LRRK2 in 72 unrelated EOPD (age-at-onset ≤50) recruited from ten movement disorders clinics in South Korea. Gene dosage change of the aforementioned genes was studied using multiple ligation-dependent probe amplification. We found four patients with PARKIN mutations, which were homozygous deletion of exon 4, compound heterozygous deletion of exon 2 and exon 4, heterozygous deletion of exon 4, and heterozygous nonsense mutation (Q40X). Four patients had PINK1 mutations; a compound heterozygous mutation (N367S and K520RfsX522) and three heterozygous mutations (G32R, R279H, and F385L). A missense mutation of SNCA (A53T) was found in a familial PD with autosomal dominant inheritance. Nine patients (12.5%) had heterozygous G2385R polymorphism of LRRK2, whereas none had G2019S mutation. However, no mutations were detected in DJ-1 and UCHL1 in our series. We identified genetic variants in PARKIN, PINK1, LRRK2, and SNCA as a cause or genetic risk factors for PD in 25% of Korean EOPD, and mutation of PARKIN was the most common genetic cause.
Literatur
3.
5.
Zurück zum Zitat Bras J, Guerreiro R, Ribeiro M, Morgadinho A, Januario C, Dias M et al (2008) Analysis of Parkinson disease patients from Portugal for mutations in SNCA, PRKN, PINK1 and LRRK2. BMC Neurol 8:1 doi:10.1186/1471-2377-8-1 PubMedCrossRef Bras J, Guerreiro R, Ribeiro M, Morgadinho A, Januario C, Dias M et al (2008) Analysis of Parkinson disease patients from Portugal for mutations in SNCA, PRKN, PINK1 and LRRK2. BMC Neurol 8:1 doi:10.​1186/​1471-2377-8-1 PubMedCrossRef
7.
8.
Zurück zum Zitat Hughes AJ, Daniel SE, Lees AJ (2001) Improved accuracy of clinical diagnosis of Lewy body Parkinson’s disease. Neurology 57:1497–1499PubMed Hughes AJ, Daniel SE, Lees AJ (2001) Improved accuracy of clinical diagnosis of Lewy body Parkinson’s disease. Neurology 57:1497–1499PubMed
9.
Zurück zum Zitat Choi JM, Woo MS, Kim SM, Ma HI, Sung YH, Lee PH et al (2008) Trinucleotide repeats number in SCA2, SCA3 and SCA17 in early-onset Parkinson’s disease. J Korean Neurol Assoc 26:23–27 Choi JM, Woo MS, Kim SM, Ma HI, Sung YH, Lee PH et al (2008) Trinucleotide repeats number in SCA2, SCA3 and SCA17 in early-onset Parkinson’s disease. J Korean Neurol Assoc 26:23–27
10.
Zurück zum Zitat Djarmati A, Guzvic M, Grunewald A, Lang AE, Pramstaller PP, Simon DK et al (2007) Rapid and reliable detection of exon rearrangements in various movement disorders genes by multiplex ligation-dependent probe amplification. Mov Disord 22:1708–1714 doi:10.1002/mds.21370 PubMedCrossRef Djarmati A, Guzvic M, Grunewald A, Lang AE, Pramstaller PP, Simon DK et al (2007) Rapid and reliable detection of exon rearrangements in various movement disorders genes by multiplex ligation-dependent probe amplification. Mov Disord 22:1708–1714 doi:10.​1002/​mds.​21370 PubMedCrossRef
11.
Zurück zum Zitat Scarciolla O, Brancati F, Valente EM, Ferraris A, De Angelis MV, Valbonesi S et al (2007) Multiplex ligation-dependent probe amplification assay for simultaneous detection of Parkinson’s disease gene rearrangements. Mov Disord 22:2274–2278 doi:10.1002/mds.21532 PubMedCrossRef Scarciolla O, Brancati F, Valente EM, Ferraris A, De Angelis MV, Valbonesi S et al (2007) Multiplex ligation-dependent probe amplification assay for simultaneous detection of Parkinson’s disease gene rearrangements. Mov Disord 22:2274–2278 doi:10.​1002/​mds.​21532 PubMedCrossRef
13.
Zurück zum Zitat Di Fonzo A, Wu-Chou YH, Lu CS, van Doeselaar M, Simons EJ, Rohe CF et al (2006) A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson’s disease risk in Taiwan. Neurogenetics 7:133–138 doi:10.1007/s10048-006-0041-5 PubMedCrossRef Di Fonzo A, Wu-Chou YH, Lu CS, van Doeselaar M, Simons EJ, Rohe CF et al (2006) A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson’s disease risk in Taiwan. Neurogenetics 7:133–138 doi:10.​1007/​s10048-006-0041-5 PubMedCrossRef
15.
16.
Zurück zum Zitat Djarmati A, Hedrich K, Svetel M, Schafer N, Juric V, Vukosavic S et al (2004) Detection of Parkin (PARK2) and DJ1 (PARK7) mutations in early-onset Parkinson disease: Parkin mutation frequency depends on ethnic origin of patients. Hum Mutat 23:525 doi:10.1002/humu.9240 PubMedCrossRef Djarmati A, Hedrich K, Svetel M, Schafer N, Juric V, Vukosavic S et al (2004) Detection of Parkin (PARK2) and DJ1 (PARK7) mutations in early-onset Parkinson disease: Parkin mutation frequency depends on ethnic origin of patients. Hum Mutat 23:525 doi:10.​1002/​humu.​9240 PubMedCrossRef
17.
Zurück zum Zitat Hattori N, Kitada T, Matsumine H, Asakawa S, Yamamura Y, Yoshino H et al (1998) Molecular genetic analysis of a novel Parkin gene in Japanese families with autosomal recessive juvenile parkinsonism: evidence for variable homozygous deletions in the Parkin gene in affected individuals. Ann Neurol 44:935–941 doi:10.1002/ana.410440612 PubMedCrossRef Hattori N, Kitada T, Matsumine H, Asakawa S, Yamamura Y, Yoshino H et al (1998) Molecular genetic analysis of a novel Parkin gene in Japanese families with autosomal recessive juvenile parkinsonism: evidence for variable homozygous deletions in the Parkin gene in affected individuals. Ann Neurol 44:935–941 doi:10.​1002/​ana.​410440612 PubMedCrossRef
18.
Zurück zum Zitat Hedrich K, Eskelson C, Wilmot B, Marder K, Harris J, Garrels J et al (2004) Distribution, type, and origin of Parkin mutations: review and case studies. Mov Disord 19:1146–1157 doi:10.1002/mds.20234 PubMedCrossRef Hedrich K, Eskelson C, Wilmot B, Marder K, Harris J, Garrels J et al (2004) Distribution, type, and origin of Parkin mutations: review and case studies. Mov Disord 19:1146–1157 doi:10.​1002/​mds.​20234 PubMedCrossRef
23.
25.
Zurück zum Zitat Hedrich K, Hagenah J, Djarmati A, Hiller A, Lohnau T, Lasek K et al (2006) Clinical spectrum of homozygous and heterozygous PINK1 mutations in a large German family with Parkinson disease: role of a single hit? Arch Neurol 63:833–838 doi:10.1001/archneur.63.6.833 PubMedCrossRef Hedrich K, Hagenah J, Djarmati A, Hiller A, Lohnau T, Lasek K et al (2006) Clinical spectrum of homozygous and heterozygous PINK1 mutations in a large German family with Parkinson disease: role of a single hit? Arch Neurol 63:833–838 doi:10.​1001/​archneur.​63.​6.​833 PubMedCrossRef
26.
Zurück zum Zitat Kay DM, Moran D, Moses L, Poorkaj P, Zabetian CP, Nutt J et al (2007) Heterozygous parkin point mutations are as common in control subjects as in Parkinson’s patients. Ann Neurol 61:47–54 doi:10.1002/ana.21039 PubMedCrossRef Kay DM, Moran D, Moses L, Poorkaj P, Zabetian CP, Nutt J et al (2007) Heterozygous parkin point mutations are as common in control subjects as in Parkinson’s patients. Ann Neurol 61:47–54 doi:10.​1002/​ana.​21039 PubMedCrossRef
27.
Zurück zum Zitat Hedrich K, Kann M, Lanthaler AJ, Dalski A, Eskelson C, Landt O et al (2001) The importance of gene dosage studies: mutational analysis of the parkin gene in early-onset parkinsonism. Hum Mol Genet 10:1649–1656 doi:10.1093/hmg/10.16.1649 PubMedCrossRef Hedrich K, Kann M, Lanthaler AJ, Dalski A, Eskelson C, Landt O et al (2001) The importance of gene dosage studies: mutational analysis of the parkin gene in early-onset parkinsonism. Hum Mol Genet 10:1649–1656 doi:10.​1093/​hmg/​10.​16.​1649 PubMedCrossRef
28.
Zurück zum Zitat Cho JW, Kim SY, Park SS, Kim HJ, Ahn TB, Kim JM et al (2007) The G2019S LRRK2 mutation is rare in Korean patients with Parkinson’s disease. Can J Neurol Sci 34:53–55PubMed Cho JW, Kim SY, Park SS, Kim HJ, Ahn TB, Kim JM et al (2007) The G2019S LRRK2 mutation is rare in Korean patients with Parkinson’s disease. Can J Neurol Sci 34:53–55PubMed
29.
Zurück zum Zitat Funayama M, Hasegawa K, Ohta E, Kawashima N, Komiyama M, Kowa H et al (2005) An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family. Ann Neurol 57:918–921 doi:10.1002/ana.20484 PubMedCrossRef Funayama M, Hasegawa K, Ohta E, Kawashima N, Komiyama M, Kowa H et al (2005) An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family. Ann Neurol 57:918–921 doi:10.​1002/​ana.​20484 PubMedCrossRef
Metadaten
Titel
Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease
verfasst von
Jung Mi Choi
Myoung Soo Woo
Hyeo-Il Ma
Suk Yun Kang
Young-Hee Sung
Seok Woo Yong
Sun Ju Chung
Joong-Seok Kim
Hae-won Shin
Chul Hyoung Lyoo
Phil Hyu Lee
Jong Sam Baik
Sang-Jin Kim
Mee Young Park
Young Ho Sohn
Jin-Ho Kim
Jae Woo Kim
Myung Sik Lee
Myoung Chong Lee
Dong-Hyun Kim
Yun Joong Kim
Publikationsdatum
01.10.2008
Verlag
Springer-Verlag
Erschienen in
Neurogenetics / Ausgabe 4/2008
Print ISSN: 1364-6745
Elektronische ISSN: 1364-6753
DOI
https://doi.org/10.1007/s10048-008-0138-0

Weitere Artikel der Ausgabe 4/2008

neurogenetics 4/2008 Zur Ausgabe

Acknowledgement to Referees

Acknowledgement to Referees 2007/2008

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.